Article History
Accepted: 2 November 2022
First Online: 21 November 2022
Declarations
:
: BSC has no conflict of interest. PYWM is a consultant for GenSight Biologics, Santhera/Chiesi, Stoke Therapeutics, and Transine Therapeutics. NJN is a consultant for GenSight Biologics, Santhera/Chiesi, Neurophoenix, and Stoke Therapeutics. PYWM and NJN and their respective institutions have received research support from Santhera/Chiesi and GenSight.
: This article does not contain any studies with human or animal subjects performed by any of the authors.